Status:
COMPLETED
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
Lead Sponsor:
Northwell Health
Conditions:
Premature Ventricular Complex
Ventricular Arrythmia
Eligibility:
All Genders
18+ years
Brief Summary
This study will measure the diagnostic sensitivity and specificity of the Medtronic CardioInsight wearable 252 electrode vest in predicting the chamber of origin of premature ventricular complexes (PV...
Detailed Description
Until recently, the only non-invasive diagnostic modality to help identify the location of ventricular arrhythmias was the 12 lead ECG. The Medtronic CardioInsight wearable vest is a recently FDA appr...
Eligibility Criteria
Inclusion
- Patients with PVCs or VT requiring EPS for:
- Symptomatic arrhythmias
- High PVC burden
- Presence of cardiomyopathy
- Risk stratification to determine which patients to offer ablative vs medical therapy and for ICD implantation if deemed high risk for sudden cardiac death.
Exclusion
- Patients in acute coronary syndrome
- Patient with congestive heart failure in acute decompensation
- Patients in rapid atrial fibrillation
- Patients requiring persistent ventricular pacing
- Patient who refuse to undergo EPS
Key Trial Info
Start Date :
January 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03831516
Start Date
January 4 2019
End Date
March 1 2022
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lenox Hill Hospital
New York, New York, United States, 10075